Skip to Main Content

Author Details

Yun Jee Seo
Institute for Refractory Cancer Research, Samsung Medical Center
2004
19
15
PMIDPaper TitleJournal TitlePublished Year
36915208Pharmacogenomic profiling reveals molecular features of chemotherapy resistance in IDH wild-type primary glioblastoma.Genome Med2023
31096737Clinical Targeted Next-Generation sequencing Panels for Detection of Somatic Variants in Gliomas.Cancer Res Treat2020
32070411Comprehensive pharmacogenomic characterization of gastric cancer.Genome Med2020
32120790Sphere-Forming Culture for Expanding Genetically Distinct Patient-Derived Glioma Stem Cells by Cellular Growth Rate Screening.Cancers (Basel)2020
30085274Distinct genomic profile and specific targeted drug responses in adult cerebellar glioblastoma.Neuro Oncol2019
30262818Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapy.Nat Genet2018
28263318Spatiotemporal genomic architecture informs precision oncology in glioblastoma.Nat Genet2017
27102443Anti-miR delivery strategies to bypass the blood-brain barrier in glioblastoma therapy.Oncotarget2016
25549722Patient-derived xenografts from non-small cell lung cancer brain metastases are valuable translational platforms for the development of personalized targeted therapy.Clin Cancer Res2015
26444992FoxM1 Promotes Stemness and Radio-Resistance of Glioblastoma by Regulating the Master Stem Cell Regulator Sox2.PLoS One2015
26084335Single-cell mRNA sequencing identifies subclonal heterogeneity in anti-cancer drug responses of lung adenocarcinoma cells.Genome Biol2015
24199994High-throughput screening (HTS) of anticancer drug efficacy on a micropillar/microwell chip platform.Anal Chem2014
25227876High-throughput, miniaturized clonogenic analysis of a limiting dilution assay on a micropillar/microwell chip with brain tumor cells.Small2014
25084005Translational validation of personalized treatment strategy based on genetic characteristics of glioblastoma.PLoS One2014
23231684Suppression of Toll-like receptor 4 activation by caffeic acid phenethyl ester is mediated by interference of LPS binding to MD2.Br J Pharmacol2013
17942705Elevated level of SUMOylated IRF-1 in tumor cells interferes with IRF-1-mediated apoptosis.Proc Natl Acad Sci U S A2007
15792349Induction of caspase-independent apoptosis in H9c2 cardiomyocytes by adriamycin treatment.Mol Cell Biochem2005
16391524Bis induces growth inhibition and differentiation of HL-60 cells via up-regulation of p27.Exp Mol Med2005
15294893CA repeats in the 3'-untranslated region of bcl-2 mRNA mediate constitutive decay of bcl-2 mRNA.J Biol Chem2004
  • 1 - 19 of 19

Recommended Authors

Vikas Patil
Princess Margaret Hospital
Career Start Year 2013
Number of shared co-authors 0
Iris Chiara Salaroglio
University of Turin
Career Start Year 2013
Number of shared co-authors 0
Meixiao Zhan
Zhuhai People's Hospital (Zhuhai Hospital Affiliated with Jinan University)
Career Start Year 2013
Number of shared co-authors 0
Guo Chen
China Pharmaceutical University
Career Start Year 2009
Number of shared co-authors 0
Yongjoon Suh
Research Institute for Natural Sciences, Hanyang University
Career Start Year 2007
Number of shared co-authors 0
Young K Song
National Cancer Institute, National Institutes of Health
Career Start Year 2007
Number of shared co-authors 0
Guan Wang
Jilin University
Career Start Year 2005
Number of shared co-authors 0
Anita B Hjelmeland
University of Alabama at Birmingham
Career Start Year 2004
Number of shared co-authors 1
Nehad M Alajez
College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation
Career Start Year 2004
Number of shared co-authors 0
Ji Zhang
Rui-Jin Hospital, Shanghai Jiao Tong University School of Medicine
Career Start Year 2004
Number of shared co-authors 0
Fan Zhang
Huaihe Hospital of Henan University
Career Start Year 2004
Number of shared co-authors 0
Xiaohu Zhang
National Center for Advancing Translational Sciences
Career Start Year 2003
Number of shared co-authors 0
Marta M Alonso
CIMA-Universidad de Navarra
Career Start Year 2001
Number of shared co-authors 1
Fan Yang
West China Second Hospital, Sichuan University
Career Start Year 2000
Number of shared co-authors 0
Iwona A Ciechomska
Nencki Institute of Experimental Biology
Career Start Year 1999
Number of shared co-authors 0
Agnieszka Bronisz
Mossakowski Medical Research Institute, Polish Academy of Sciences
Career Start Year 1999
Number of shared co-authors 1
Krishna P Bhat
Department of Neurosurgery at the University of Texas MD Anderson Cancer Center
Career Start Year 1998
Number of shared co-authors 7
Erxi Wu
Livestrong Cancer Institutes, Dell Medical School, The University of Texas at Austin
Career Start Year 1997
Number of shared co-authors 0
Jong Bae Park
Henan-Macquarie University Joint Centre for Biomedical Innovation, Henan University
Career Start Year 1997
Number of shared co-authors 19
Dong Lin
Fujian Medical University Cancer Hospital and Fujian Cancer Hospital
Career Start Year 1996
Number of shared co-authors 0
Christopher Ryan Miller
University of Illinois at Urbana-Champaign
Career Start Year 1996
Number of shared co-authors 2
Shi-Yuan Cheng
Northwestern University Feinberg School of Medicine
Career Start Year 1996
Number of shared co-authors 3
Seiji Kondo
Fukuoka University
Career Start Year 1992
Number of shared co-authors 0
Frank B Furnari
University of California San Diego
Career Start Year 1992
Number of shared co-authors 0
Jeremy N Rich
UPMC Hillman Cancer Center, University of Pittsburgh Medical Center
Career Start Year 1992
Number of shared co-authors 8
Xiao-Nan Li
Northwestern University
Career Start Year 1992
Number of shared co-authors 2
Qimin Zhan
Peking University Cancer Hospital
Career Start Year 1989
Number of shared co-authors 0
Wei Zhang
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 3
Lori S Hart
Children's Hospital of Philadelphia, USA. [2] Center for Childhood Cancer Research
Career Start Year 1987
Number of shared co-authors 0
Erwin G Van Meir
Heersink School of Medicine, University of Alabama at Birmingham
Career Start Year 1984
Number of shared co-authors 6

Collaborators

Do-Hyun Nam
Samsung Medical Center, Sungkyunkwan University School
Co-authored papers 13
Jung-Il Lee
Gangnam Severance Hospital
Co-authored papers 9
Ho Jun Seol
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 8
Jason K Sa
Korea University, College of Medicine
Co-authored papers 7
Doo-Sik Kong
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 7
Hee Jin Cho
Touro College of Osteopathic Medicine
Co-authored papers 7
Woong-Yang Park
Samsung Genome Institute, Samsung Medical Center
Co-authored papers 7
Donggeon Kim
Institute for Refractory Cancer Research, Samsung Medical Center
Co-authored papers 6
Hye Won Lee
Yonsei University College of Medicine, Severance Hospital
Co-authored papers 5
Kyeung Min Joo
Cancer Stem Cell Research Center, Samsung Biomedical Research Institute
Co-authored papers 4
Sang Shin
Feinberg School of Medicine, Northwestern University
Co-authored papers 4
Yong Jae Shin
Cancer Stem Cell Research Center, Samsung Biomedical Research Institute
Co-authored papers 4
Hyun Ju Kang
Genomic Medicine Institute, Medical Research Center, Seoul National University
Co-authored papers 4
Harim Koo
Korea University College of Medicine
Co-authored papers 4
Seung Won Choi
Samsung Medical Center, Sungkyunkwan University
Co-authored papers 4
Jung Won Choi
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 3
Raul Rabadan
Columbia University Vagelos College of Physicians and Surgeons
Co-authored papers 3
Hyemi Shin
Research Institute for Future Medicine, Samsung Medical Center
Co-authored papers 3
Sung Tae Kim
Busan Paik Hospital, Inje University
Co-authored papers 3
Yeup Yoon
Sungkyunkwan University
Co-authored papers 3
Jiguang Wang
The Hong Kong University of Science and Technology
Co-authored papers 3
Chul-Kee Park
College of Medicine, Seoul National University
Co-authored papers 3
Jin-Ku Lee
Seoul National University, College of Medicine
Co-authored papers 3
Yong-Jun Kwon
Luxembourg Institute of Health
Co-authored papers 3
Zhaoqi Liu
University of Chinese Academy of Sciences
Co-authored papers 2
Mykola Bordyuh
Columbia University
Co-authored papers 2
Jeongwu Lee
Lerner Research Institute, Cleveland Clinic
Co-authored papers 2
Joon Seol Bae
Research Institute of Future Medicine, Samsung Medical Center
Co-authored papers 2
Erik Ladewig
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Jeeyun Lee
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 2
Release 1.2